Amanda Stebbins

8PUBLICATIONS
60CO-AUTHORS
Nanotoxicology, health and safetyCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesEuropean Union law
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 02, 2026
Outcomes of Patients With New Left Bundle Branch Block After TAVR: TVT Registry Insights.

Nickpreet Singh, David J Cohen, Shmuel Chen

|Nov 26, 2025
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLE.

Christopher L Mosher, Amanda Stebbins, Courtney E Lamberton

|Feb 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.

Guillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck

|Oct 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors.

Saket Girotra, Amanda Stebbins, Lisa Wruck

Pageof 2